Menu
Back to Journals » OncoTargets and Therapy » Volume 4
Review
Rationale for targeting VEGF, FGF, and PDGF for the treatment of NSCLC
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 14,720 | Dovepress* | 10,826+ | 3,305 | 14,131 | |
| PubMed Central* | 3,894 | 2,799 | 6,693 | ||
| Totals | 14,720 | 6,104 | 20,824 | ||
|
*Since 30 May 2011 +Since July 2016 |
|||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 2 | 0 | 0 | 0 | 0 | 2 |
View citations on PubMed Central and Google Scholar